Experimental evidence showed that SYK inhibitor significantly alleviated DSS-induced and TNBS-induced colitis by regulating TGFβ, TNFα, and IL-1β (Biagioli et al., 2017), which are also important in the course of PSC. Here, TNF is linked to colitis.